Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 10/27/20
Due: 10/27/21
Phase: N/A
Priority: Normal
Start: 10/14/19
End: 12/09/22
Due: 12/09/23
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 04/30/21
Due: 04/30/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome | NCT03047980 | Anne Comi, MD | user2@example.com | None | 2017-01-31 | 2020-10-27 | 2021-10-27 | - | - | 2025-07-14 |
| Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | NCT04447846 | Anne Comi, MD | user2@example.com | None | 2019-10-14 | 2022-12-09 | 2023-12-09 | - | - | 2025-07-14 |
| Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome | NCT02332655 | Anne Comi, MD | user2@example.com | None | 2014-12-31 | 2021-04-30 | 2022-04-30 | - | - | 2025-07-14 |